ITCI

Intra-Cellular Therapies Inc.

Delisted

ITCI was delisted on the 1st of April, 2025.

343 hedge funds and large institutions have $6.14B invested in Intra-Cellular Therapies Inc. in 2024 Q1 according to their latest regulatory filings, with 54 funds opening new positions, 121 increasing their positions, 126 reducing their positions, and 39 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
343
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
8
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$314M
Puts
$96.1M
Net Calls
Net Calls Change

Top Buyers

1 +$65.6M
2 +$47M
3 +$23.7M
4
Citadel Advisors
Citadel Advisors
Florida
+$22.5M
5
Ameriprise
Ameriprise
Minnesota
+$21.3M

Top Sellers

1 -$107M
2 -$66.5M
3 -$35.6M
4
DTC
Deep Track Capital
Connecticut
-$34.6M
5
Holocene Advisors
Holocene Advisors
New York
-$24.4M
Name Holding Trade Value Shares
Change
Change in
Stake
126
$2.93M
127
$2.84M
128
$2.69M
129
$2.66M
130
$2.63M
131
$2.63M
132
$2.57M
133
$2.57M
134
$2.55M
135
$2.48M
136
$2.44M
137
$2.44M
138
$2.41M
139
$2.37M
140
$2.36M
141
$2.32M
142
$2.1M
143
$2.08M
144
$2.01M
145
$1.86M
146
$1.85M
147
$1.77M
148
$1.73M
149
$1.73M
150
$1.7M